Qingxia Yu
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
-
- Platelet Disorders and Treatments
Papers in
-
- Renal cell carcinoma treatment 2
-
- Tryptophan and brain disorders 1
- Co-authors
- Yu Kong (1 shared paper)Senthil Kumaran Satyanarayanan (1 shared paper)Tao Ye (1 shared paper)Jiaming Liu (1 shared paper)Yuhe Zhang (1 shared paper)Kuan‐Pin Su (1 shared paper)Xutang Tao (1 shared paper)Weiguo Zhang (1 shared paper)
In The Last Decade
Qingxia Yu
11 papers receiving 326 citations
Peers
Comparison fields: 5 of 85
- Biological Psychiatry 52
- Hematology 37
- Neurology 22
- Molecular Biology 133
- Physiology 47
Countries citing papers authored by Qingxia Yu
This map shows the geographic impact of Qingxia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingxia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingxia Yu more than expected).
Fields of papers citing papers by Qingxia Yu
This network shows the impact of papers produced by Qingxia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingxia Yu. The network helps show where Qingxia Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingxia Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 189 | |
| 2 | 2017 | 59 | |
| 3 | 2012 | 33 | |
| 4 | 2015 | 23 | |
| 5 | 2023 | 9 | |
| 6 | 2018 | 6 | |
| 7 | Laparoscopic partial nephrectomy for T1a renal tumors is safe and feasible. | 2011 | 4 |
| 8 | 2022 | 3 | |
| 9 | 2021 | 2 | |
| 10 | 2024 | 2 | |
| 11 | 2025 | 1 |
About Qingxia Yu
Qingxia Yu is a scholar working on Pulmonary and Respiratory Medicine, Biological Psychiatry, Behavioral Neuroscience, Endocrine and Autonomic Systems and Oncology, having authored 11 papers that have together received 331 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (2 papers), Renal cell carcinoma treatment (2 papers), Pediatric Urology and Nephrology Studies (1 paper), Tryptophan and brain disorders (1 paper), Tuberous Sclerosis Complex Research (1 paper), Crystal Structures and Properties (1 paper), Pharmacological Effects of Natural Compounds (1 paper) and Neuroendocrine regulation and behavior (1 paper). The work is most often cited by research in Biological Psychiatry (52 citations), Hematology (37 citations), Neurology (22 citations), Molecular Biology (133 citations) and Physiology (47 citations). Qingxia Yu has collaborated with scholars based in China, Australia and Taiwan. Frequent co-authors include Yu Kong, Senthil Kumaran Satyanarayanan, Tao Ye, Jiaming Liu, Yuhe Zhang, Kuan‐Pin Su, Xutang Tao, Weiguo Zhang, Shaojun Zhang and Zeliang Gao. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Acta Physiologica, PLoS ONE, Journal of Hazardous Materials and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.